Actively Recruiting
How to Differentiate and Treat Cystic Lesions in the Anterior Mediastinum (DETECTION)
Led by Maastricht University Medical Center · Updated on 2024-11-20
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Maastricht University Medical Center
Lead Sponsor
E
Erasmus Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research focuses on cystic lesions in the anterior mediastinum, such as thymic cysts, bronchogenic cysts, pericardial cysts, cystic thymoma, and cystic teratoma. The study aims to improve the accuracy of diagnosing these cystic lesions by reviewing cases from 2000 to 2022. It is an observational, multicenter trial led by Maastricht University Medical Center to better understand these conditions and their treatment options. The study does not involve any specific intervention or treatment but collects and analyzes patient data, characteristics, complications, and comorbidities related to anterior mediastinal cysts. The research includes patients who have undergone radiological imaging and have approval for follow-up. Data from these patients will be reviewed to assess diagnostic accuracy and clinical outcomes. Participants will be involved through data collection based on their existing medical records and follow-up approvals. Researchers will evaluate diagnostic success rates and associated patient information over the study period. No additional procedures or treatments are administered as part of the study. The study began in December 2022 and will continue until December 2027, aiming to gather extensive clinical data on these cystic lesions.
CONDITIONS
Brief Title
How to Differentiate and Treat Cystic Laesions in the Anterior Mediastinum (DETECTION)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cysts located in the anterior mediastinum
- Includes thymic cysts, bronchogenic cysts, pericardial cysts, cystic thymoma, and cystic teratoma
- Participants must be 18 years or older
- Must have radiological imaging available
- Must have approval for follow-up
You will not qualify if you...
- Patients younger than 18 years old
- Patients without radiological imaging
- Patients without approval for follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Ongoing throughout the study period
Participants undergo radiological imaging to identify and differentiate cystic lesions in the anterior mediastinum.
Visits as needed for imaging assessments
Duration - Up to 7 years
Participants are observed over time to assess patient characteristics, complications, and comorbidities related to cystic lesions.
Follow-up visits depending on individual approval for follow-up
Trial Site Locations
Total: 1 location
1
Maastricht UMC
Maastricht, Limburg, Netherlands
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here